HLK Biotech Holding Group, Inc. (AMHD)

0.0010 0.0000 (0.00%) At close: 03:46PM EDT

HLK Biotech Holding Group, Inc.

2612 Granby Street
Norfolk, VA 23517
United States
646-926-3568
https://www.amelotholdings.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Anna Petinova	Interim Vice President of Administration, Interim Vice President of Finance, Treasurer and Director	N/A	N/A	1964
Mr. Hank Midden	Vice President - Operations	N/A	N/A	1942
Mr. John Gernannt	Head of Investor & Public Relations Issues	N/A	N/A	N/A
Mr. Peter R. N. Maharaj	Vice President - Marketing and President - Southern Hardwoods	N/A	N/A	1966
Mr. Thomas Cripe	Senior Vice President of Business & Technology Development	N/A	N/A	N/A
Mr. Tyler Macallister	Controller	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. was incorporated in 1998 and is headquartered in Norfolk, Virginia.

Corporate governance

HLK Biotech Holding Group, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.